DURECT Corporation (DRRX): Price and Financial Metrics

DRRX POWR Grades

• DRRX scores best on the Value dimension, with a Value rank ahead of 68.66% of US stocks.
• The strongest trend for DRRX is in Stability, which has been heading down over the past 26 weeks.
• DRRX's current lowest rank is in the Stability metric (where it is better than 1.2% of US stocks).

DRRX Stock Summary

• As for revenue growth, note that DRRX's revenue has grown -60.48% over the past 12 months; that beats the revenue growth of merely 3.67% of US companies in our set.
• The volatility of DURECT CORP's share price is greater than that of 94.14% US stocks with at least 200 days of trading history.
• Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for DRRX comes in at -139.93% -- higher than that of just 3.18% of stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to DURECT CORP are BCDA, GSIT, CRIS, HYLN, and BYSI.
• Visit DRRX's SEC page to see the company's official filings. To visit the company's web site, go to www.durect.com.

DRRX Valuation Summary

• In comparison to the median Healthcare stock, DRRX's EV/EBIT ratio is 100.68% lower, now standing at -0.1.
• DRRX's EV/EBIT ratio has moved up 7.4 over the prior 243 months.

Below are key valuation metrics over time for DRRX.

DRRX Growth Metrics

Its 5 year net income to common stockholders growth rate is now at 32.71%.
• Its 4 year net cashflow from operations growth rate is now at 112.96%.
• The 2 year revenue growth rate now stands at -51.5%.

Over the past 49 months, DRRX's revenue has gone down $11,210,000.

The table below shows DRRX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	23.265	-28.98	-31.872
2022-06-30	13.453	-34.11	-39.378
2022-03-31	13.68	-32.161	-36.973
2021-12-31	13.977	-37.311	-36.265
2021-09-30	5.489	-34.58	-24.897
2021-06-30	6.007	-35.905	-24.252

DRRX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• DRRX has a Quality Grade of C, ranking ahead of 38.99% of graded US stocks.
• DRRX's asset turnover comes in at 0.065 -- ranking 305th of 680 Pharmaceutical Products stocks.
• CCXI, LCI, and BHC are the stocks whose asset turnover ratios are most correlated with DRRX.

The table below shows DRRX's key quality metrics over time.